Navigation Links
PURE Bioscience Announces DuraBan International as Distributor of SDC-Based Disinfectant
Date:7/31/2008

hown to allow or cause microbial adaptation, resistance, mutation, diffusion, or migration and easily bonds to almost any surface, creating unlimited applications for this breakthrough technology. For more information, please visit http://www.durabanintl.com.

About PURE Bioscience

PURE Bioscience develops and markets technology-based bioscience products that provide solutions to numerous global health challenges, including Staph (MRSA). PURE's proprietary high efficacy/low toxicity bioscience technologies, including its silver dihydrogen citrate-based antimicrobials, represent innovative advances in diverse markets and lead today's global trend toward industry and consumer use of "green" products while providing competitive advantages in efficacy and safety. Patented SDC is an electrolytically generated source of stabilized ionic silver which formulates well with other compounds. As a platform technology, SDC is distinguished from competitors in the marketplace because of its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it. PURE is headquartered in El Cajon, California (San Diego metropolitan area). Additional information on PURE is available at http://www.purebio.com.

This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, acceptance of the Company's current and future products and services in the marke
'/>"/>

SOURCE PURE Bioscience
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
2. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
3. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
4. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
5. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
6. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
7. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
8. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
9. Todd R. Nelson Named Chief Executive Officer of eBioscience, Inc.
10. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
11. Pressure BioSciences, Inc. Issued First Patent in Canada

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...hfirmReplikinsLtd.,whichhasanalyzedtheH1N1virus,ge...utbreak,andprogressofthecurrentH1N1pandemic,todayi...datashowsthatthelethalityoftheH1N1("SwineFlu")viru...,scurrentoutbreakinthespringof2009torestingnon-epi...ectivitycount,however,remainsincreased. ,, Then...
(Date:11/25/2009)...tlinker.comannouncesthatanewmarketresearchreportis...rketAnalysisandForecaststo2013 ,, http://www....-Analysis-and-Forecasts-to-2013.html ,, Brazil...Summary ,, Thereportprovidesdetailedanalysisan...ioethanolmarketinparticular.Italsohelpsinanalyzing...
(Date:11/24/2009)...vestment bank KTA Capital,s client Neuren Pharmace...vertible note private placement with a U.S. instit...ed by KTA Capital as Neuren,s exclusive placement ...York (PRWEB) November 23, 2009 -- The independent ...TA Capital") has announced that its client Ne...
(Date:11/24/2009)...ployment grew by 29,000 jobs in October, and the ...th during the U.S. recession. However, clinics and... systems are coming closer to having to actually c...rs. , (Vocus) November 24... in October despite the shedding of jobs in most o...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4
...poration (Pink Sheets: MNCN), a global health comp...r positive, long term benefit to the agricultural ...closed on the acquisition of Modular Process Const...the LLC interests of MPC for $500,000 of Series B ...of $0.50 cents per share. The purchase price was f...
...ray Incorporated,(Nasdaq: ARAY ), a global leade...at 10 percent of its U.S. installed base has signe...ervice. Treatment planning by medical physicists,i...adiosurgery treatment,delivery. , Accuray,s tr...mers,maximize utilization of their CyberKnife Syst...
... announced today,that Scopus(R), its flagship prod...mp;C) database, was chosen by the Australian Resea...or Australia (ERA) initiative. , The ERA initi...a,s higher,education institutions using a combinat...comprised of experienced, internationally-recogniz...
Other Biology Technology:Mach One Closes on Acquisition of Biopharmaceutical Design & Engineering Firm 210 Percent of U.S. Installed Base Signs on to Use Accuray Treatment Planning Service 210 Percent of U.S. Installed Base Signs on to Use Accuray Treatment Planning Service 310 Percent of U.S. Installed Base Signs on to Use Accuray Treatment Planning Service 4The Australian Research Council Selects Scopus for the Evaluation of the Australian Research Landscape 2The Australian Research Council Selects Scopus for the Evaluation of the Australian Research Landscape 3
(Date:11/25/2009)...Ghrelin, a hormone produced in the stomach, may be...ment of Parkinson,s disease, Yale School of Medici...cent issue of the Journal of Neuroscience . , P...dopamine neurons in an area of the midbrain known ...dopamine production. Reduced production of dopami...
(Date:11/25/2009)...On September 11, firefighters, police officers and...t in the World Trade Center complex. They battled ...arched for survivors, tackled fires and evacuated ...ained an estimated 17,000 people. And making their...ations: frightened workers and their relatives jam...
(Date:11/25/2009)...MADISON, WI, NOVEMBER 25, 2009 Soil is the linchp..., and hydrosphere meet. Despite that, many student... but nothing more. Soil science educators are chal...ublic recognize the critical importance of soil in...soil science and earth science teachers at Univers...
Breaking Biology News(10 mins):Hormone ghrelin can boost resistance to Parkinson's disease 2Magic box for mission impossible 2Magic box for mission impossible 3It's not just dirt! 2Brain Protein Tied to Retardation 59897 1Informed Consent Goes Mobile Helping Patients and Clinicians Cut Confusion and Paperwork 59894 1Informed Consent Goes Mobile Helping Patients and Clinicians Cut Confusion and Paperwork 59894 2Informed Consent Goes Mobile Helping Patients and Clinicians Cut Confusion and Paperwork 59894 3Lake Health Celebrates Grand Opening of TriPoint Medical Center 59890 1Lake Health Celebrates Grand Opening of TriPoint Medical Center 59890 2Lake Health Celebrates Grand Opening of TriPoint Medical Center 59890 3Lake Health Celebrates Grand Opening of TriPoint Medical Center 59890 4Lake Health Celebrates Grand Opening of TriPoint Medical Center 59890 5Lake Health Celebrates Grand Opening of TriPoint Medical Center 59890 6Lake Health Celebrates Grand Opening of TriPoint Medical Center 59890 7
.... , Plant researchers from McGill University an...ounced a major breakthrough in a developmental pro...r the first time the reversal of what is called ep... important to develop a better understanding of ge...anced crops that produce higher yields, are more r...
...nited States that are at the highest risk of susta...enough to the dangers posed by rising temperatures...entury of climate change that has already signific...rns and has already had widespread ecological and ... that the United States will experience at least a...
.... , , Sometimes physicists resort to tried and t...Planck Institute for Metals Research, the Universi...ave constructed micromachines using the same trick...where the masts and rigging of the sailing ship ar...me way, the scientists link the valves, pumps and ...
Other Biology News:Plants display 'molecular amnesia' 2Plants display 'molecular amnesia' 3Most US organizations not adapting to climate change 2Most US organizations not adapting to climate change 3Ship-in-a-bottle kit on a microchip 2Ship-in-a-bottle kit on a microchip 3
...ress Cloning Checker Kits provide two highly effic...fter transformation without time-consuming plasmid...od in Kit I, all you need to do is to transfer par...e transformation plates into the solutions provide...
Mouse Anti-GLP-1 Monoclonal Antibody, Unconjugated, Clone HYB 147-12 from Santa Cruz Biotechnology, Inc.
Rat Anti-p19ARF Monoclonal Antibody, Unconjugated, Clone 5-C3-1 from Upstate
EDTA, tetrasodium salt from GE Healthcare, formerly Amersham Biosciences
Biology Products: